HIMS Latest Headlines

Hims & Hers Health Ignites Rally on Weight-Loss Hype

at www.tipranks.com (Sat, 20-Jun 10:02 AM)

Barclays Raises HIMS Stock Price Target on Strong GLP-1 Growth

at www.tipranks.com (Thu, 18-Jun 9:12 AM)

Barclays Keeps Their Buy Rating on Hims & Hers Health (HIMS)

at www.tipranks.com (Thu, 18-Jun 2:27 AM)

FDA renews crackdown on GLP-1 compounders

at seekingalpha.com (Wed, 17-Jun 7:13 AM)

Hims & Hers Taps Longevity Expert Dr. Anant Vinjamoori to Lead Medical Strategy—A Move Signaling Major Expansion in Preventive and Personalized Care

Market Chameleon (Thu, 4-Jun 9:04 AM)

Hims & Hers Expands Subscriber Benefits: Ten Leading Wellness Brands Now Included—A Comprehensive Look at the New Program

Market Chameleon (Fri, 29-May 7:08 AM)

Hims & Hers Unveils $300M Convertible Notes Plan to Boost Global Growth and AI Investment

Market Chameleon (Mon, 18-May 7:30 AM)

Hims & Hers Brings Marketing Visionary Kofi Amoo-Gottfried into Board Nominee Lineup—A Strategic Step in Healthcare Innovation

Market Chameleon (Tue, 28-Apr 8:49 AM)

Hims & Hers Schedules Q1 2026 Results for May 11: Investors Await Key Updates Ahead of Evercore Conference

Market Chameleon (Tue, 14-Apr 7:07 AM)

Hims & Hers Expands Access to FDA-Approved GLP-1 Medications Through Novo Nordisk Collaboration

Market Chameleon (Fri, 27-Mar 7:28 AM)